COMPANIES COVERED
GlaxoSmithKlineDownload FREE Report Sample
Download Free sampleAnal cancer is a disease in which malignant (cancer) cells form in the tissues of the anus. Being infected with the human papillomavirus (HPV) increases the risk of developinganal cancer. Signs of anal cancer include bleeding from theanus or rectum or a lump near the anus.
Anal Cancer Market contains market size and forecasts of Anal Cancer in Global, including the following market information:
Global Anal Cancer Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Anal Cancer market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Fluorouracil Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Anal Cancer include GlaxoSmithKline, Spectrum Pharmaceuticals, Hospira, Global BioPharma, Advaxis, Amgen Inc, Atara Biotherapeutics, Bayer and Cell Medica, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Anal Cancer companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Anal Cancer Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Anal Cancer Market Segment Percentages, by Type, 2021 (%)
Fluorouracil
Cisplatin
Carboplatin
Other
Global Anal Cancer Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Anal Cancer Market Segment Percentages, by Application, 2021 (%)
Hospitals
Long-Term Care Centers
Pharmacies
Other
Global Anal Cancer Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Anal Cancer Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Anal Cancer revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Anal Cancer revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
GlaxoSmithKline
Spectrum Pharmaceuticals
Hospira
Global BioPharma
Advaxis
Amgen Inc
Atara Biotherapeutics
Bayer
Cell Medica
Eli Lilly
Genticel
ISA Pharmaceuticals
Merck?Co
Millennium Pharmaceuticals
Novartis
??Ono Pharmaceutical
Oryx
PDS Biotechnology
Sun Pharma
Speak to our Custom Research Team and get the Custom Research in a budget
Custom ResearchFrequently Asked Questions ?
A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.
A license granted to multiple users.
A license granted to a single business site/establishment.
A license granted to all employees within organisation access to the product.
Upto Working 24 to 48 hrs
Upto 72 hrs max - Weekends and Public Holidays
Online Payments with PayPal and CCavenue
Wire Transfer/Bank Transfer
Hard Copy
Industry Market SizeSWOT AnalysisIndustry Major PlayersRevenue ForecastsHistorical and Forecast GrowthProfitability Analysis
